Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-01-10 @ 1:46 AM
Study NCT ID:
NCT00101920
Status:
COMPLETED
Last Update Posted:
2010-10-15
First Post:
2005-01-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)
Sponsor:
Amgen
Organization: